ARTICLE | Top Story
MedImmune acquires CV company AlphaCore
April 3, 2013 11:32 PM UTC
The MedImmune LLC biologics unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) acquired cardiovascular company AlphaCore Pharma (Ann Arbor, Mich.). Details of the deal were not disclosed. AlphaCore is develo...